IPSC - Century Therapeutics GAAP EPS of -$2.30 revenue of $2.2M March, 14 2024 11:45 AM Century Therapeutics Inc. 2024-03-14 11:45:29 ET More on Century Therapeutics Century Therapeutics: More Attention Doesn't Mean You Should Buy Into INK Cell Therapy Seeking Alpha’s Quant Rating on Century Therapeutics Historical earnings data for Century Therapeutics Financial information for Century Therapeutics For further details see: Century Therapeutics GAAP EPS of -$2.30, revenue of $2.2M